Faculty Information - WATANABE Daisuke

（Last updated : 2023-12-15 20:41:08）

WATANABE Daisuke
Department School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine

Position Assistant Professor

■ Published papers

1.	Original article	Comparisons of risk factors for post-treatment renal dysfunction between the two major subtypes of primary aldosteronism 2023/12/12
2.	Original article	Effect of GH Deficiency Caused by Nonfunctioning Pituitary Masses on Serum C-reactive Protein Levels. 2023/11
3.	Original article	Effects of Aliskiren Monotherapy versus Amlodipine Monotherapy in Hypertensive Patients with Obesity or Type 2 Diabetes Mellitus. 2023/10
4.	Original article	Cardiovascular risk assessments in patients with cortisol-producing adenoma: impact of clinical features and genetic characteristics 2023/09/11
5.	Original article	Hyperuricemia and the Severity of Coronavirus Disease 2019 in Japan: A Retrospective Cohort Study - An Inseparable Relation with Hypertension and Chronic Kidney Disease 2023
6.	Original article	Comparison of the usefulness of the cardio-ankle vascular index and augmentation index as an index of arteriosclerosis in patients with essential hypertension. 2021/12
7.	Original article	Immunohistochemistry for (pro)renin receptor in humans 2021/07/28
8.	Original article	Transient Leukopenia After Radioactive Iodine Treatment in Patients With Graves’ Disease: A Retrospective Cohort Study 2021/03/06
9.	Original article	Comparison of Shortened with Standard Saline Infusion Test for Primary Aldosteronism Diagnostics 2020/05/08
10.	Original article	Cosyntropin stimulation in adrenal vein sampling improves the judgment of successful adrenal vein catheterization and outcome prediction for primary aldosteronism 2020/04/30
11.	Original article	Adrenal n(pro)renin receptor expression and serum soluble (pro)renin receptor concentration in primary aldosteronism 2020
12.	Case report	Primary aldosteronism in Klinefelter’s syndrome: two cases 2019/12
13.	Original article	Serum-soluble (pro)renin receptor concentration as a biomarker for organ damage in primary aldosteronism. 2019/12
14.	Case report	ACTH-Dependent Cyclic Cushing Syndrome Triggered by Glucocorticoid Excess Through a Positive-Feedback Mechanism. 2019/05
15.	Original article	Fatal Fournier's gangrene caused by Clostridium ramosum in a patient with central diabetes insipidus and insulin-dependent diabetes mellitus: a case report. 2018/08
16.	Original article	Greater reductions in plasma aldosterone with aliskiren in hypertensive patients with higher soluble (Pro)renin receptor level. 2018/06
17.	Original article	Complete remission of hypertension in a hemodialysis patient after adrenalectomy for primary aldosteronism and renal transplantation. 2018/05
18.	Original article	Prediction of response to medical therapy by serum soluble (pro)renin receptor levels in Graves' disease. 2018
19.	Original article	Body mass index and contralateral ratio predict outcome following unilateral adrenalectomy in primary aldosteronism. 2017/12
20.	Original article	The relationships between the differences in central blood pressure and brachial blood pressure and other factors in patients with essential hypertension 2017
21.	Original article	Evaluation of insulin sensitivity and secretion in primary aldosteronism. 2016/09
22.	Case report	Osteomalacia, severe thoracic deformities and respiratory failure in a young woman with anorexia nervosa. 2015/04
23.	Review article	Serum soluble (pro)renin receptor levels in patients with essential hypertension. 2014
24.	Original article	Prediction of gestational diabetes mellitus by soluble (pro)renin receptor during the first trimester. 2013/06
25.	Original article	Renoprotective effects of an angiotensin II receptor blocker in experimental model rats with hypertension and metabolic disorders 2009
Display 5 items
Display all(25)

■ Academic conference presentation

1.	Association between cardiac (pro)renin receptor expression and myocardial hypertrophy in human 2021/04
2.	Primary Aldosteronism in Klinefelter's Syndrome: Two Cases Report 2018/09/22
3.	Primary Hyperparathyroidism in a Patient with Primary Aldosteronism 2018/09/22
4.	Renoprotective Effect of Direct Renin Inhibitor Monotherapy in Hypertensive Patients with Type 2 Diabetes or Obesity 2018/09/14
5.	Serum soluble (pro)renin receptor concentration is correlated with organ dysfunctions in patients with primary aldosteronism 2018/09
6.	An old patient with acromegaly treated with consideration of past history and preventing frailty 2018/02/09
7.	(Pro)renin receptor immunohistochemistry in human organs 2016/09
8.	A novel biomarker urinary soluble (pro)renin receptor excretion is associated with urineph 2016/09
9.	Evaluation of Insulin Sensitivity and Secretion in Primary Aldosteronism. (Pro)renin receptor immunohistochemistry in human organs. 2016/09
10.	Relationships between serum soluble (pro)renin receptor levels and endocrine or metabolic factors in patients with essential hypertension. 2015/09
11.	Serum soluble (pro)renin receptor levels in patients undergoing hemodialysis 2015/09
12.	A case of hemodialysis patient with primary aldosteronism which was difficult to differentiate from pheochromocytoma 2015/05
13.	A Circulating Soluble (Pro)Renin Receptor Level and Its Changes with Growth Hormone replacement in Patients with Growth Hormone Deficiency 2014/06/21
14.	Associations between renal function and indices of renin-angiotensin system in patients with essential hypertension 2014/05
15.	Effects of the direct renin inhibitor on renin-angiotensin system in hypertensive patients with chronic kidney disease 2014/05
16.	Serum soluble (Pro)renin receptor levels in maintenance hemodialysis patients 2014/05
17.	Clinical implications of the difference in central blood pressure and brachial blood pressure in patients with essential hypertension 2014/04
18.	CVD therapy for unresectable pheochromocytoma 2013/08
19.	Periodic ectopic Cushing's syndrome potentially evoked by glucocorticoid excess 2013/06/16
Display 5 items
Display all(19)

■ Education

2005/04～2009/03

〔Doctoral course〕, Tokyo Women's Medical University, Completed,